Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy

Pulmonary Pharmacology and Therapeutics

Volumn 44, Issue , 2017, Pages 24-29

  Trabattoni, D ^a   Clerici, M ^b   Centanni, S ^b   Mantero, M ^b   Garziano, M ^a   Blasi, F ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Community acquired pneumonia; Immunomodulatory activity; Immunostimulants; Pidotimod

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; HLA ANTIGEN CLASS 1; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; LEVOFLOXACIN; PIDOTIMOD; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; ANTIINFECTIVE AGENT; IMMUNOLOGIC FACTOR; PYROGLUTAMIC ACID; THIAZOLIDINE DERIVATIVE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; UPREGULATION; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMMUNITY ACQUIRED INFECTION; COMPARATIVE STUDY; DRUG EFFECTS; HOSPITALIZATION; IMMUNOLOGY; INNATE IMMUNITY; PNEUMONIA; PROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; LEVOFLOXACIN; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; PYRROLIDONECARBOXYLIC ACID; THIAZOLIDINES; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85015625605     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2017.03.005     Document Type: Article

References (19)

1. [1] Little, P., Stuart, B., Moore, M., Coenen, S., Butler, C.C., Godycki-Cwirko, M., Mierzecki, A., Chlabicz, S., Torres, A., Almirall, J., Davies, M., Schaberg, T., MÖlstad, S., Blasi, F., De Sutter, A., Kersnik, J., Hupkova, H., Touboul, P., Hood, K., Mullee, M., O'Reilly, G., Brugman, C., Goossens, H., Verheij, T., on behalf of the GRACE consortium. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect. Dis. 13 (2013), 123–129.
2. [2] Butler, C.C., Hood, K., Verheij, T., Little, P., Melbye, H., Nuttall, J., Kelly, M.J., Mölstad, S., Godycki-Cwirko, M., Almirall, J., Torres, A., Gillespie, D., Rautakorpi, U., Coenen, S., Goossens, H., Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ, 338, 2009, b2242.
3. [3] Petersen, I., Johnson, A.M., Islam, A., Duckworth, G., Livermore, D.M., Hayward, A.C., Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ 335 (2007), 982–985.
4. [4] Mongardon, N., Max, A., Bouglé, A., Pène, F., Lemiale, V., Charpentier, J., Cariou, A., Chiche, J.D., Bedos, J.P., Mira, J.P., Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Crit. Care, 16, 2012, R155.
5. [5] Annane, D., Bellissant, E., Cavaillon, J.M., Septic shock. Lancet 365 (2005), 63–78.
6. [6] Menéndez, R., Torres, A., Zalacaìn, R., Aspa, J., Villasclaras, J.J.M., Borderìas, L., Benìtez Moya, J.M., Ruiz-Manzano, J., Rodrìguez de Castro, F., Blanquer, J., Pérez, D., Puzo, C., Sànchez Gascòn, F., Gallardo, J., Alvarez, C., Molinos, L., Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 59 (2004), 960–965.
7. [7] Antunes, G., Evans, S.A., Lordan, J.L., Frew, A.J., Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur. Respir. J. 20 (2002), 990–995.
8. [8] Menéndez, R., Cavalcanti, M., Reyes, S., Mensa, J., Martinez, R., Marcos, M.A., Filella, X., Niederman, M., Torres, A., Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 63 (2008), 447–452.
9. [9] Prina, E., Ceccato, A., Torres, A., New aspects in the management of pneumonia. Crit. Care 20 (2016), 267–276.
10. [10] Zuccotti, G.V., Mameli, C., Pidotimod: the past and present. Ital. J. Pediatr. 39 (2013), 75–78.
11. [11] Carta, S., Silvestri, M., Rossi, G.A., Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression. 10 Ital. J. Pediatr. 39 (2013), 29–38.
12. [12] Hu, X., Zhang, W., Wang, L., Wan, N., Wang, B., Li, W., Hua, H., Hu, X., Shan, F., The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: pidotimod(PTD). Hum. Vaccine Immunother. 8 (2012), 1250–1258.
13. [13] Giagulli, C., Noerder, M., Avolio, M., Becker, P.D., Fiorentini, S., Guzman, C.A., Caruso, A., Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level. Int. Immunopharmacol. 9 (2009), 1366–1373.
14. [14] Esposito, S., Garziano, M., Rainone, V., Trabattoni, D., Biasin, M., Senatore, L., Marchisio, P., Rossi, M., Principi, N., Clerici, M., Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia. J. Transl. Med. 13 (2015), 288–298.
15. [15] Zuccotti, G.V., Mameli, C., Trabattoni, D., Beretta, S., Biasin, M., Guazzarotti, L., Clerici, M., Immunomodulating activity of Pidotimod in children with Down syndrome. J. Biol. Regul. Homeost. Agents 27 (2013), 253–258.
16. [16] Kumar, H., Kawai, T., Akira, S., Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388 (2009), 621–625.
17. [17] Janeway, C.A., Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 20 (2002), 197–216.
18. [18] Wiesner, J., Vilcinskas, A., Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1 (2010), 440–464.
19. [19] Fernandez-Botran, R., Uriarte, S.M., Arnold, F.W., Rodriguez-Hernandez, L., Rane, M.J., Peyrani, P., Wiemken, T., Kelley, R., Uppatla, S., Cavallazzi, R., Blasi, F., Morlacchi, L., Aliberti, S., Jonsson, C., Ramirez, J.A., Bordon, J., Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia. Inflammation 37 (2014), 1158–1166.